Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

Peter J. Munson, David Rodbard · Analytical Biochemistry · 1980 · 8.5K citations

Life Sciences, Chemistry, Biomolecular Modeling +11

Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents

Richard A. Glennon, Milt Titeler, J.D. McKenney · Life Sciences · 1984 · 636 citations

Medicine, Pharmacology, Neuropharmacology +3

3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.

Giuseppe Battaglia, S.Y. Yeh, Elizabeth O’Hearn et al. · Journal of Pharmacology and Experimental Therapeutics · 1987 · 459 citations

Medicine, Neuroscience, Pharmacology +16

MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons

George Battaglia, S.Y. Yeh, Errol B. De Souza · Pharmacology Biochemistry and Behavior · 1988 · 313 citations

Life Sciences, Neurobiology, Neuroscience +14

Effects of enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices

Michael P. Johnson, Andrew J. Hoffman, David E. Nichols · European Journal of Pharmacology · 1986 · 307 citations

Medicine, Neuroscience, Pharmacology +12